Literature DB >> 9269430

Evaluation of the concept of "hypoxic fraction" as a descriptor of tumor oxygenation status.

S M Evans1, W T Jenkins, M Shapiro, C J Koch.   

Abstract

The presence and significance of tumor hypoxia has been recognized since the 1950's. Hypoxic cells in vitro and in animal tumors in vivo are documented to be three times more resistant to radiation-induced killing compared to aerobic cells. There is now evidence that tumor hypoxia is treatment-limiting in many human cancers. One common way to describe the extent of hypoxia in individual and groups of tumors is the "hypoxic fraction." This measurement infers that cells are present in only two radiobiologically significant states: oxygenated and hypoxic. In this paper, we demonstrate the qualitative and quantitative presence of hypoxic tumor cells using the oxygen dependent metabolism of the 2-nitroimidazole, EF5. Two assumptions concerning the calculation and interpretation of the hypoxic fraction are considered. The first is the use of multiple animals to describe the radiation response at a given radiation dose. We hypothesize that the presence of intertumor variability in radiation response due to hypoxia could negatively influenced the characterization of the change in slope required to calculate the hypoxic fraction. The studies presented herein demonstrate heterogeneity of radioresponse due to hypoxic fraction within and between tumor lines. The 9L subcutaneous tumor studied in air-breathing rats demonstrates a 2 log variation in surviving fraction at 17 Gy. The Morris 7777 hepatoma, in contrast, showed little variability of radiation response. Our second question addresses the limitations of using the "hypoxic fraction" to describe the radiation response of a tumor. This calculated value infers that radiobiological hypoxia is a binary measurement: that a tumor contains two cell populations, aerobic cells with maximal radiosensitivity and hypoxic cells with maximal radioresistance. The classic work of Thomlinson and Gray, however, implies the presence of an oxygen gradient from tumors vessel through the tissues. In both the 9L and Q7 tumors, flow cytometric analysis of EF5 binding demonstrates a continuous range of cellular pO2 levels. These studies suggest that: 1) there is extensive intertumor variability of radiation response in certain tumor lines; 2) the variability in radiation response between individual tumors in a group may affect the ability to describe a particular tumor type's "hypoxic fraction" and 3) The oxygen status of tumor cells is a continuum. This realization affects the ability to apply a binary concept such as the "hypoxic fraction" effectively in radiobiology.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9269430     DOI: 10.1007/978-1-4615-5865-1_26

Source DB:  PubMed          Journal:  Adv Exp Med Biol        ISSN: 0065-2598            Impact factor:   2.622


  9 in total

Review 1.  Impact of anemia in patients with head and neck cancer treated with radiation therapy.

Authors:  Kenneth Hu; Louis B Harrison
Journal:  Curr Treat Options Oncol       Date:  2005-01

Review 2.  Prognostic Value of Fluorine-19 MRI Oximetry Monitoring in cancer.

Authors:  Fanny Chapelin; Roberto Gedaly; Zachary Sweeney; Liza J Gossett
Journal:  Mol Imaging Biol       Date:  2021-10-27       Impact factor: 3.488

3.  Regional hypoxia in glioblastoma multiforme quantified with [18F]fluoromisonidazole positron emission tomography before radiotherapy: correlation with time to progression and survival.

Authors:  Alexander M Spence; Mark Muzi; Kristin R Swanson; Finbarr O'Sullivan; Jason K Rockhill; Joseph G Rajendran; Tom C H Adamsen; Jeanne M Link; Paul E Swanson; Kevin J Yagle; Robert C Rostomily; Daniel L Silbergeld; Kenneth A Krohn
Journal:  Clin Cancer Res       Date:  2008-05-01       Impact factor: 12.531

4.  Imaging and analytical methods as applied to the evaluation of vasculature and hypoxia in human brain tumors.

Authors:  Sydney M Evans; Kevin W Jenkins; W Timothy Jenkins; Thomas Dilling; Kevin D Judy; Amy Schrlau; Alexander Judkins; Stephen M Hahn; Cameron J Koch
Journal:  Radiat Res       Date:  2008-12       Impact factor: 2.841

Review 5.  Hypoxia Imaging As a Guide for Hypoxia-Modulated and Hypoxia-Activated Therapy.

Authors:  Jeffrey R Brender; Yu Saida; Nallathamby Devasahayam; Murali C Krishna; Shun Kishimoto
Journal:  Antioxid Redox Signal       Date:  2022-01       Impact factor: 8.401

6.  Influence of acute hypoxia and radiation quality on cell survival.

Authors:  Walter Tinganelli; Ning-Yi Ma; Cläre Von Neubeck; Andreas Maier; Corinna Schicker; Wilma Kraft-Weyrather; Marco Durante
Journal:  J Radiat Res       Date:  2013-07       Impact factor: 2.724

7.  Influence of chronic hypoxia and radiation quality on cell survival.

Authors:  Ning-Yi Ma; Walter Tinganelli; Andreas Maier; Marco Durante; Wilma Kraft-Weyrather
Journal:  J Radiat Res       Date:  2013-07       Impact factor: 2.724

8.  Radiotherapy combined with an engineered Salmonella typhimurium inhibits tumor growth in a mouse model of colon cancer.

Authors:  Xiande Liu; Shengnan Jiang; Linghua Piao; Feng Yuan
Journal:  Exp Anim       Date:  2016-06-10

Review 9.  Emerging Bismuth Chalcogenides Based Nanodrugs for Cancer Radiotherapy.

Authors:  Jia Huang; Qiong Huang; Min Liu; Qiaohui Chen; Kelong Ai
Journal:  Front Pharmacol       Date:  2022-02-18       Impact factor: 5.810

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.